Respostas Clínicas Cochrane
As Respostas Clínicas Cochrane (RCCs) proporcionam um ponto de entrada amigável, digerível e clinicamente focado para as pesquisas rigorosas das revisões sistemáticas Cochrane. Elas são desenvolvidas para serem acionáveis e para respaldar a tomada de decisão no local de atendimento, e foram adicionadas a seções relevantes do texto principal do Best Practice.
- In adults with acute bronchitis who do not have any other underlying pulmonary disease or acute respiratory illness, what are the benefits and harms of beta2-agonists?
- How do point‐of‐care diagnostic tests for acute respiratory infection affect antibiotic prescribing behavior in primary care?
- How do communication strategies affect antibiotic prescribing behavior for acute respiratory infection in primary care?
- For people with respiratory infection, how do delayed compare with immediate or no antibiotic prescriptions?
- In people with acute bronchitis, is there randomized controlled trial evidence to support the use of antibiotics?
- What are the benefits and harms of azithromycin compared with amoxicillin or amoxicillin/clavulanic acid in people with acute lower respiratory tract infections?
O uso deste conteúdo está sujeito ao nosso aviso legal